India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
India Approves First Dengue Vaccine For Wider Public Protection Why in the News ? The Drug Controller General of India (DCGI) has granted market authorisation to QDENGA (TAK-003), making it the first dengue vaccine approved in India. The vaccine is indicated for individuals aged 4–60 years and offers protection against all four dengue virus serotypes. …
Read MoreICMR Study Reveals Widespread Dyslipidemia Among Indian Adults Today Why in the News ? A recent ICMR-INDIAB study has found that 87.3% of Indian adults have at least one abnormal lipid level, with low HDL (good cholesterol) being the most common abnormality. The findings highlight the growing burden of cardiovascular disease (CVD) and the need …
Read MoreUnited States Reports Major Cyclosporiasis Foodborne Disease Outbreak Why in the News ? The United States has reported a major outbreak of cyclosporiasis, with over 1,645 confirmed cases across 34 States. The outbreak has renewed global attention on foodborne diseases, food safety practices, surveillance of parasitic infections, and the importance of diplomatic engagement in international …
Read MoreGlobal Immunisation Gaps Persist Despite Coverage Improvements Why in the News ? The WHO-UNICEF Estimates of National Immunization Coverage (WUENIC) 2025 report reveals that 679,000 Indian children remained zero-dose in their first year of life. Although global vaccination coverage has improved through enhanced multilateral engagement, it has not yet returned to pre-pandemic levels. Global Immunisation …
Read MoreEXPERIMENTAL DRUG TRIAL FOR BUNDIBUGYO EBOLA VIRUS Why in the News? Clinical Trial: The Democratic Republic of Congo (DRC) has launched a clinical trial to evaluate Gilead Sciences’ experimental antiviral drug Obeldesivir as a post-exposure treatment for the ongoing Bundibugyo Ebola virus outbreak in Congo and Uganda. Research Initiative: The study seeks to determine whether …
Read MoreKERALA’S CRUDE BIRTH RATE FALLS BELOW 10 FOR THE FIRST TIME Why in the News? Historic Demographic Shift: Kerala’s Vital Statistics Report 2024 shows that the Crude Birth Rate (CBR) has fallen below 10 for the first time, indicating an advanced stage of demographic transition with implications for regional economic integration and workforce planning. Population …
Read MoreSTUDY TO CONTAIN ANTIMICROBIAL-RESISTANT NEONATAL SEPSIS BEGINS IN INDIA Why in the News? India Joins Global Trial: India has joined the NeoSep1 international clinical trial to evaluate effective antibiotic combinations for antimicrobial-resistant neonatal sepsis, with the first participants enrolled at JIPMER, Puducherry and PGIMS, Rohtak, demonstrating strategic alignment with global health priorities. Public Health Significance: …
Read MoreCOUNTRIES RESUME TALKS TO FINALISE WHO PANDEMIC TREATY Why in the News? PABS Negotiations: WHO member states have resumed negotiations in Geneva to finalise the Pathogen Access and Benefit-Sharing (PABS) mechanism under the Pandemic Agreement through enhanced diplomatic engagement and multilateral engagement. Fresh Urgency: The ongoing Ebola outbreak in the Democratic Republic of the Congo …
Read MoreWHO FLAGS GROWING INEQUITIES IN GLOBAL CANCER CARE Why in the News? WHO Report Released: The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) released the Global Status Report on Cancer, 2026, highlighting widening inequalities in cancer prevention, diagnosis, treatment, and survival amid growing strategic competition in global healthcare systems. …
Read MoreAIR POLLUTION PLAN NEEDS POLITICAL WILL, NOT AN EYE ON THE ELECTION CYCLE Syllabus: GS2: Issues related to development and management of social sector Health Why in the News? The Delhi Government’s Electric Vehicle (EV) Policy 2.0 seeks to accelerate the transition towards electric mobility by phasing out registrations of conventional vehicles. While the initiative …
Read More
